| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Mar-07 | | Total Revenue | 81,982 | 59,702 | 55,960 | | Cost of Revenue | 44,716 | 33,135 | 31,789 | | | Gross Profit | 37,266 | 26,567 | 24,171 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 37,925 | 23,406 | 21,444 | | Non Recurring |
-
|
-
|
-
| | Others | 1,347 | 928 | 708 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,006) | 2,233 | 2,019 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (55) | (110) | (42) | | Earnings Before Interest And Taxes | (2,061) | 2,123 | 1,977 | | Interest Expense | 926 | 708 | 528 | | Income Before Tax | (2,987) | 1,415 | 1,449 | | Income Tax Expense | (1,373) | 623 | 469 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,614) | 792 | 980 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,614) | 792 | 980 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,614) | $792 | $980 |
|
1.27% Nasdaq 0.00%
Income Statement
